Channel name was changed to «Ophthalmology step 2 videos & books 2026»

Channel
Ophthalmology step 2 videos & books 2026
@Ophthalmologyvideos
On this record: Topic · Growth · Engagement · What this channel posts · Posts · Polls · Citations · Telegram's recommendations · Cite this entry
7,161subscribers
+35 since we began measuring on 26 August 2026
Risers and fallers across the register · movement among entries of 3,162–10,000.
Register entry
| Telegram ID | -1001400385641 |
|---|---|
| Type | Channel |
| Username | @Ophthalmologyvideos |
| Created | Between 1 September 2018 and 31 October 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 26 August 2026 |
| Last confirmed live | 18 September 2026 |
| Measurements held | 8 |
| Confirmed unchanged | 1 time, most recently 18 September 2026 |
| On Telegram | t.me/Ophthalmologyvideos |
Topic
Education — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 12 September 2026 and assigned it the closest of 31 fixed categories, at 99% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 18 Sept 2026, 14:17 | 7,161 | +7 |
| 14 Sept 2026, 15:57 | 7,154 | +3 |
| 11 Sept 2026, 09:16 | 7,151 | +10 |
| 6 Sept 2026, 10:21 | 7,141 | +5 |
| 1 Sept 2026, 23:09 | 7,136 | +5 |
| 30 Aug 2026, 06:07 | 7,131 | +5 |
| 26 Aug 2026, 18:00 | 7,126 | no change |
| 26 Aug 2026, 17:45 | 7,126 | first reading |
Engagement
20 posts held, back to 30 March 2023 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 30 October 2025. An engagement rate over an empty window would be a number about nothing.
What this channel posts
- Video runtime
- 1m 20s
- Average length
- 1m 20s
Measured directly from 1 video with a duration reading, out of the posts we hold for this channel — not this channel’s whole posting history, only the sample this register has actually read. An exact reading to the second, taken from the post itself rather than from Telegram’s own rounded chrome, so it carries no ≈ mark.
Recent posts
🎉 FREE NBME Self-Assessment! 🎉 Get NBME Form 25 at no cost—limited-time offer! ⏰ Don't Miss Out! 👉 Sign Up Now: 👇👇👇👇👇👇👇 🔗 nbmeway.com/nbme/signup.php Stay updated on Telegram: 💬 @NBMECMS
☄️ 2025 USMLE Recalls: Dominate the Exam! ☄️ Your success is our mission. 🙂 No more stress, no more guesswork. Our proven recall strategies will give you the edge you need to crush the USMLE. 👑 Why settle for average when you can be exceptional? With expert guidance and a tailored approach, you’ll be ready to achieve your highest score yet. 🔥Don’t wait—your future is calling. 👋 Take action now and secure your sp…
☄️ 2025 USMLE Recalls: Dominate the Exam! ☄️ Your success is our mission. 🙂 No more stress, no more guesswork. Our proven recall strategies will give you the edge you need to crush the USMLE. 👑 Why settle for average when you can be exceptional? With expert guidance and a tailored approach, you’ll be ready to achieve your highest score yet. 🔥Don’t wait—your future is calling. 👋 Take action now and secure your sp…
🥳 2025 usmle recalls 🥳 🤩Rock your USMLE exam 🤩 😇Don't let the stress of the exam impact your success any longer. 😇Our proven recall strategies will provide you with the tools you need to confidently and accurately ace the exam . With our expert guidance and personalized approach, you can finally achieve the USMLE score you've been dreaming of😎. 👋Don't wait any longer to take control of your future. Sign up for o…
💥🆕CBSE | CCSE 🔄💥 🔝 Stop wasting time on useless resources – dominate your study game!💯 👌 Study smarter, not harder – let's crush those exams together! ✔️ ⭐️Take chances, no regrets! Seize the opportunity for excellence! 🥇 ✉️ For membership and details⬇️ ➡️ @CBSE_CCSE_SHELF_EXAMS 🩵 Join our channel for instant updates: ⬇️ ➡️ @CBSE_CCSE_SHELF_exam
🥳 2025 usmle recalls 🥳 🤩Rock your USMLE exam 🤩 😇Don't let the stress of the exam impact your success any longer. 😇Our proven recall strategies will provide you with the tools you need to confidently and accurately ace the exam . With our expert guidance and personalized approach, you can finally achieve the USMLE score you've been dreaming of😎. 👋Don't wait any longer to take control of your future. Sign up for o…
Educational objective: Mild to moderate cancer-related pain can usually be managed with nonopioid analgesics. However, if initial interventions are not effective, intermittent doses of short-acting opioids should be offered. If the pain requires frequent dosing or if bedtime dosing does not provide relief through the night, a long-acting opioid may be added.
Which of the following is the most appropriate immediate next step in this patient's pain management?
- A. Heating pad14%
- B. Local glucocorticoid injection12%
- C. Short-acting opioid24%
- D. Substitution of ibuprofen with naproxen24%
- E . Systemic glucocorticoid8%
- F Topical capsaicin9%
- G. Transdermal fentanyl patch9%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
A 71-year-old man comes to the ·office due to worsening low back pain. The patient is having significant pain with movement that is limiting his activity, as well as nocturnal pain that is disrupting his sleep. He has had no lower extremity weakness or numbness and no bladder or bowel dysfunction. He is taking ibuprofen 3-4 times a day, and it is not controlling his pain. The patient has a history of prostate cancer …
Educational objective: Chemotherapy-induced peripheral neuropathy typically presents as a symmetric, distal, sensory neuropathy that spreads in a stocking-glove pattern. Common causative agents include platinum-based medications (eg, cisplatin}, taxanes (eg, paclitaxel), and Vinca alkaloids (eg, vincristine }.
Which of the following is the most likely diagnosis?
- A . Anterior cerebral artery occlusion13%
- B. Chemotherapy-induced peripheral neuropathy47%
- C. Diabetic peripheral neuropathy26%
- D. Spinal cord compression9%
- E. Tabes dorsalis from syphilis4%
Shares as published, totalling 99%. No per-option vote count is published by Telegram, so none is shown.
Showing the 12 most recent of 20 posts we hold for @Ophthalmologyvideos. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Polls
The 3 polls we hold for this entry, as Telegram rendered them when we read the post. A poll’s figures keep moving after that, so each one is dated.
Which of the following is the most appropriate immediate next step in this patient's pain management?
- A. Heating pad14%
- B. Local glucocorticoid injection12%
- C. Short-acting opioid24%
- D. Substitution of ibuprofen with naproxen24%
- E . Systemic glucocorticoid8%
- F Topical capsaicin9%
- G. Transdermal fentanyl patch9%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Which of the following is the most likely diagnosis?
- A . Anterior cerebral artery occlusion13%
- B. Chemotherapy-induced peripheral neuropathy47%
- C. Diabetic peripheral neuropathy26%
- D. Spinal cord compression9%
- E. Tabes dorsalis from syphilis4%
Shares as published, totalling 99%. No per-option vote count is published by Telegram, so none is shown.
Which of the following is the most likely explanation for this patient's new symptoms?
- A. COMT inhibitor pharmacotherapy18%
- B. Dementia with Lewy bodies17%
- C. Dopamine agonist pharmacotherapy43%
- D. Frontotemporal dementia11%
- E. lvlAO-B inhibitor pharmacotherapy11%
Shares as published. No per-option vote count is published by Telegram, so none is shown.
Percentages only — there are no per-option vote counts here, because Telegram publishes none. The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.
The shares need not add up to 100. Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.
Read from the 20 most recent posts we hold, published 30 March 2023 to 30 October 2025. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.
Forward network
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Mentions
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
Appears in Telegram’s recommendations for other channels
The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.
@paedsvideos · 50,152
Telegram ranks this channel #10 of 69 here — alongside 68 others — read 26 August 2026
@forensicmedicine_videos · 28,533
Telegram ranks this channel #13 of 71 here — alongside 70 others — read 9 September 2026
This channel appears in 2 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 18 September 2026 — this entry's latest reading, not the date you are reading this.
“Ophthalmology step 2 videos & books 2026” (@Ophthalmologyvideos), 7,161 subscribers as measured 18 September 2026. Telegram Register, tgregister.com/channel/Ophthalmologyvideos.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.